Genetic testing of all breast cancer patients may pay off October 7, 2019 -- Multigene testing of all women with breast cancer is "extremely cost-effective," according to a large study of data from the U.S. and U.K. published online in JAMA Oncology on October 3. But though the case is building for more testing, the debate is far from over. Discuss
Gestalt touts tie-ups for cancer image workflow October 7, 2019 -- Pathology software company Gestalt Diagnostics announced two tie-ups related to the interpretation of cancer images -- one with artificial intelligence specialist MindPeak for breast cancer image analysis and a separate alliance with Flagship Biosciences covering support for testing of programmed cell death ligand 1 (PD-L1).
Blood centers claim FDA safety rules threaten patient access October 4, 2019 -- The U.S. Food and Drug Administration (FDA) should continue to assess the effects of new guidance for controlling the risk of bacterial contamination of platelets in blood collection establishments and transfusion services, according to America's Blood Centers, a large network of community-based, independent blood programs in North America.
AI algorithm can accurately diagnose appendicitis October 2, 2019 -- By analyzing lab values and ultrasound data, an artificial intelligence (AI) algorithm can be highly accurate for diagnosing acute appendicitis and could potentially help avoid unnecessary surgery in two-thirds of patients without appendicitis, according to research published online September 25 in PLOS One. Discuss
Medicare genetic testing fraud spurs federal charges September 30, 2019 -- Thirty-five individuals have been charged in relation to more than $2.1 billion in fraudulent billing for expensive, unnecessary genetic cancer testing of Medicare patients, according to the U.S. Department of Justice.
CAP President Dr. Patrick Godbey sees pathology in driver's seat of medicine September 26, 2019 -- ORLANDO, FL - Nowadays, it's hard to think of a disease process that the clinical laboratory doesn't outright diagnose or manage. But it hasn't always been that way, commented Dr. Patrick Godbey, the new president of the College of American Pathologists (CAP), in an interview at the organization's annual meeting. Discuss
Sysmex, LabCorp extend hematology automation pact September 26, 2019 -- Sysmex America and LabCorp announced they are extending their hematology automation agreement. Sysmex America is providing LabCorp Diagnostics' primary reference laboratories with Sysmex's upgraded XN series technology.
CAP paints rosy picture of pathology jobs September 25, 2019 -- ORLANDO, FL - The outlook for pathologist jobs in the U.S. appears good, in contrast with recent pessimistic reports, according to a survey of practice leaders discussed at the College of American Pathologists (CAP) annual meeting. Discuss